These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6327087)
1. Hybridocytochemistry with 2-acetylaminofluorene-modified probes. Landegent JE; Baan RA; Hoeijmakers JH; Raap AK; Van der Ploeg M Cell Biol Int Rep; 1984 Mar; 8(3):186. PubMed ID: 6327087 [No Abstract] [Full Text] [Related]
2. 2-Acetylaminofluorene-modified probes for the indirect hybridocytochemical detection of specific nucleic acid sequences. Landegent JE; Jasen in de Wal N; Baan RA; Hoeijmakers JH; Van der Ploeg M Exp Cell Res; 1984 Jul; 153(1):61-72. PubMed ID: 6203769 [TBL] [Abstract][Full Text] [Related]
3. Hot spots of frameshift mutations induced by the ultimate carcinogen N-acetoxy-N-2-acetylaminofluorene. Fuchs RP; Schwartz N; Daune MP Nature; 1981 Dec; 294(5842):657-9. PubMed ID: 7031481 [No Abstract] [Full Text] [Related]
4. Electron microscopic visualization of N-acetoxy-N-2-acetylaminofluorene binding sites in ColE1 DNA by means of specific antibodies. de Murcia G; Lang MC; Freund AM; Fuchs RP; Duane MP; Sage E; Leng M Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6076-80. PubMed ID: 293703 [TBL] [Abstract][Full Text] [Related]
5. Infectivity and reconstitution of TMV RNA modified with N-acetoxy-2-acetylaminofluorene or benzol [a] pyrene 7,8-dihydrodiol 9,10 oxide. Singer B; Pulkrabek P; Weinstein IB; Grunberger D Nucleic Acids Res; 1980 May; 8(9):2067-74. PubMed ID: 6776494 [TBL] [Abstract][Full Text] [Related]
6. Preferential promutagenic lesions at exons 7-8 of human p53 genomic DNA induced by the direct-acting hepatocarcinogens N-nitroso-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene. Ho YS; Lin JK Cancer Lett; 1995 Aug; 95(1-2):39-47. PubMed ID: 7656242 [TBL] [Abstract][Full Text] [Related]
7. Repair of damage by N-acetoxy-2-acetylaminofluorene in Bloom's syndrome. Remsen JF Mutat Res; 1980 Aug; 72(1):151-4. PubMed ID: 7442692 [No Abstract] [Full Text] [Related]
8. Mechanisms for the recognition of chemically-modified DNA by peptides and proteins. Helene C; Toulme JJ; Behmoaras T; Cazenave C Biochimie; 1982; 64(8-9):697-705. PubMed ID: 6814516 [No Abstract] [Full Text] [Related]
9. C-alkylation of N-acetoxy-N-2-acetylaminofluorene: effects on its reaction with DNA in vitro. Saint-Ruf G; Loukakou PE; Spodheim-Maurizot M Cancer Biochem Biophys; 1984 Jun; 7(2):89-99. PubMed ID: 6088032 [TBL] [Abstract][Full Text] [Related]
10. An ELISA for detection of DNA-bound carcinogen using a monoclonal antibody to N-acetoxy-2-acetylaminofluorene-modified DNA. Ball SS; Quaranta V; Shadravan F; Walford RL J Immunol Methods; 1987 Apr; 98(2):195-200. PubMed ID: 3571986 [TBL] [Abstract][Full Text] [Related]
11. Quantification of adducts formed in DNA treated with N-acetoxy-2-acetylaminofluorene or N-hydroxy-2-aminofluorene: comparison of trifluoroacetic acid and enzymatic degradation. Tang M; Lieberman MW Carcinogenesis; 1983 Aug; 4(8):1001-6. PubMed ID: 6307542 [TBL] [Abstract][Full Text] [Related]
12. DNA adduct formation and removal in N-acetoxy-2-acetylaminofluorene-exposed cultured cells and in organs from rats fed 2-acetylaminofluorene. Poirier MC; Yuspa SH; True B; Laishes BA Basic Life Sci; 1983; 24():619-35. PubMed ID: 6860277 [No Abstract] [Full Text] [Related]
13. Alkaline stability of guanosine and some of its derivatives modified by the carcinogen N-acetoxyacetylaminofluorene. Spodheim-Maurizot M; Dreux M; Saint-Ruf G; Leng M Nucleic Acids Res; 1979 Dec; 7(8):2347-56. PubMed ID: 42882 [TBL] [Abstract][Full Text] [Related]
14. DNA binding spectrum of the carcinogen N-acetoxy-N-2-acetylaminofluorene significantly differs from the mutation spectrum. Fuchs RP J Mol Biol; 1984 Jul; 177(1):173-80. PubMed ID: 6748082 [TBL] [Abstract][Full Text] [Related]
15. The reproducibility of individual estimations in the covalent binding of N-acetoxy-2-acetylaminofluorene to DNA and in the induction of unscheduled DNA synthesis. Pero RW; Lund-Pero M Mutat Res; 1983 Jun; 120(4):219-24. PubMed ID: 6855791 [No Abstract] [Full Text] [Related]
16. A novel method for the small scale synthesis of N-acetoxy-2-acetylaminofluorene and its adducts. Van Roy FP; Moyer GH; Austin GE Cancer Lett; 1981 Mar; 12(1-2):147-52. PubMed ID: 7272998 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, modification with N-acetoxy-2-acetylaminofluorene and physicochemical studies of DNA model compound d(TACGTA). Sharma M; Box HC Chem Biol Interact; 1985 Dec; 56(1):73-88. PubMed ID: 4075447 [TBL] [Abstract][Full Text] [Related]
19. Modification of PM2 DNA with N-acetoxy-2-acetylaminofluorene: changes in buoyant density, electrophoretic mobility and electron microscopic structure. Thielmann HW; Kuhn C Cancer Lett; 1980 Feb; 8(4):343-51. PubMed ID: 7370970 [TBL] [Abstract][Full Text] [Related]
20. Effect of culture conditions, cell type, and species of origin on the distribution of acetylated and deacetylated deoxyguanosine C-8 adducts of N-acetoxy-2-acetylaminofluorene. Poirier MC; Williams GM; Yuspa SH Mol Pharmacol; 1980 Nov; 18(3):581-7. PubMed ID: 7464821 [No Abstract] [Full Text] [Related] [Next] [New Search]